Review on anti-alzheimer drug development: approaches, challenges and perspectives

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Review on anti-alzheimer drug development: approaches, challenges and perspectives

Abstract: Alzheimer has many crucial factors that should be considered in order to get better results from clinical trials. Benzimidazole and its isosteres represent significant scaffolds for designing potential multi-target anti-alzheimer molecules.

Cited by 6 publications

References 277 publications

Advances in understanding biomarkers and treating neurological diseases – Role of the cerebellar dysfunction and emerging therapies

Advances in understanding biomarkers and treating neurological diseases – Role of the cerebellar dysfunction and emerging therapies

Exploring the therapeutic potential of dioscin and diosgenin in neurological disorders

Multimodal spatiotemporal drug assessment platform based on a microelectrode neural network chip in Alzheimer’s disease

Contact Info

Product

Resources

About